Premium
Real‐world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center
Author(s) -
Zeb Lawangeen,
Mhaskar Rahul,
Lewis Suzanna,
Patel Nishit S.,
Sadhwani Divya,
Patel Nupur,
Ekhlassi Erfon,
Lu Yuanyuan,
SeminarioVidal Lucia
Publication year - 2021
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14826
Subject(s) - apremilast , medicine , discontinuation , psoriasis , thalidomide , dermatology , plaque psoriasis , center (category theory) , drug , family medicine , pharmacology , psoriatic arthritis , multiple myeloma , chemistry , crystallography
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom